LOTUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 USD | -.--% |
|
-.--% | +16.28% |
| 2023 | Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries | MT |
| 2021 | Thai oil firm PTT expands pharma business with $475 million Alvogen deal | RE |
Quotes 5-day view
Delayed Quote OTC Markets| 25/04/2024 | |
|---|---|
| Last | 0.005 $ |
| Volume | 10 000 |
| Change | +∞% |
| Opening | 0.01 |
| High | 0.01 |
| Low | 0.01 |
Performance
| 3 months | +42.86% | ||
| 6 months | -9.09% | ||
| Current year | +16.28% | ||
| 1 year | -50.00% | ||
| 3 years | -90.00% | ||
| 5 years | -37.50% | ||
| 10 years | -79.84% |
Volumes
marketsDaily volume
10 000
Estimated daily volume
10 000
Avg. Volume 20 sessions
24 883
Daily volume ratio
0.40
Avg. Volume 20 sessions USD
124.42
Record volume 1
1 946 556
Record volume 2
1 226 303
Record volume 3
1 169 388
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
14 722 577
Net sales (USD)
72 696 618
Number of employees
383
Sales / Employee (USD)
189 808
Free-Float
100 %
Free-Float capitalization (USD)
13 472 577
Average Daily Capital Traded
0%
Highs and lows
1 month
0.00
0.01
Current year
0.000.01
1 year
0.000.01
3 years
0.000.10
5 years
0.000.22
10 years
0.000.22
Indicators
Moving average 5 days
0.01
Moving average 20 days
0.01
Moving average 50 days
0.01
Moving average 100 days
0.01
Price spread / (MMA5)
-.--%
Price spread / (MMA20)
-.--%
Price spread / (MMA50)
+2.00%
Price spread / (MMA100)
-.--%
STIM
RSI 9 days
48.65
RSI 14 days
49.50
Sector Comparison - Generic Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | +16.28% | -50.00% | 14.72M | ||
| -0.52% | +0.31% | +19.98% | +56.82% | 43.48B | ||
| -2.73% | +0.19% | +20.67% | +36.08% | 22.65B | ||
| +1.47% | +3.33% | +14.56% | - | 14.73B | ||
| +0.33% | +1.11% | +14.32% | +54.75% | 13.79B | ||
| +0.95% | +5.28% | +44.72% | +91.53% | 12.04B | ||
| -0.80% | +0.24% | -8.37% | -16.47% | 7.08B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| +0.46% | +3.18% | +11.90% | +26.54% | 5.47B | ||
| +0.31% | +2.11% | -2.27% | -11.16% | 4.81B | ||
| +0.65% | +1.47% | +6.69% | +12.61% | 4.72B | ||
| +0.40% | +0.80% | +15.00% | +13.45% | 4.2B | ||
| -2.26% | +0.23% | +29.88% | +154.41% | 3.69B | ||
| -0.68% | -2.41% | +23.34% | +94.64% | 3.56B | ||
| +6.71% | +8.68% | +14.41% | +85.65% | 3.6B | ||
| Average | +0.27% | +1.87% | +15.79% | +42.22% | ||
| Weighted average by Cap. | -0.19% | +1.69% | +18.23% | +49.96% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +17.65% | ||
| 2023 | -57.50% | ||
| 2022 | -41.00% | ||
| 2021 | +54.09% | ||
| 2020 | -23.61% | ||
| 2019 | +260.00% | ||
| 2018 | +11.11% | ||
| 2017 | +63.64% | ||
| 2016 | -68.57% | ||
| 2015 | -2.78% | ||
| 2014 | -52.00% | ||
| 2013 | +36.36% | ||
| 2012 | -96.86% | ||
| 2011 | -86.49% | ||
| 2010 | +1.17% | ||
| 2009 | +539.68% | ||
| 2008 | -81.64% | ||
| 2007 | -56.40% | ||
| 2006 | -37.50% |
- Stock Market
- Equities
- LTUS Stock
- Quotes Lotus Pharmaceuticals, Inc.
